Certified by Founder
Lodge
Fore Biotherapeutics
start up
United States
- Philadelphia, PA
- 25/08/2023
- Series D
- $75,000,000
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics. Deeply rooted in science and innovation, our vision is to compassionately contribute to solving cancer.
- Industry Biotechnology
- Website https://fore.bio/
- LinkedIn https://www.linkedin.com/company/forebiotherapeutics/about/
osapiens | $100,000,000 | (Jan 15, 2026)
Musical AI | $4,500,000 | (Jan 15, 2026)
Harmattan AI | $200,000,000 | (Jan 15, 2026)
Aikido Security | $60,000,000 | (Jan 15, 2026)
Tive | $20,000,000 | (Jan 15, 2026)
IO River | $20,000,000 | (Jan 15, 2026)
Flip (US) | $20,000,000 | (Jan 15, 2026)
MeetCaria | $1,000,000 | (Jan 15, 2026)
SkyFi | $12,700,000 | (Jan 15, 2026)
Axol Bioscience Ltd. | $28,000,000 | (Jan 15, 2026)
Titl | $2,500,000 | (Jan 15, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)